GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Net Change in Cash

Valeo Pharma (TSX:VPH) Net Change in Cash : C$-2.65 Mil (TTM As of Jul. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Valeo Pharma's Net Change in Cash for the three months ended in Jul. 2024 was C$0.24 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jul. 2024 was C$-2.65 Mil.


Valeo Pharma Net Change in Cash Historical Data

The historical data trend for Valeo Pharma's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Net Change in Cash Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Net Change in Cash
Get a 7-Day Free Trial 0.32 2.50 -0.79 20.46 -15.00

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.34 -2.27 2.08 -2.70 0.24

Valeo Pharma Net Change in Cash Calculation

Valeo Pharma's Net Change in Cash for the fiscal year that ended in Oct. 2023 is calculated as

Valeo Pharma's Net Change in Cash for the quarter that ended in Jul. 2024


Net Change in Cash for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valeo Pharma Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeo Pharma Business Description

Traded in Other Exchanges
N/A
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Executives
Luc Mainville Senior Officer
100079 Canada Inc. 10% Security Holder
Richard J. Mackay Director, Director or Senior Officer of 10% Security Holder
Steve Saviuk Director, Director or Senior Officer of 10% Security Holder, Senior Officer
Jeffrey Michael Skinner Senior Officer
Frederic Fasano Director
Guy Paul Allard Director or Senior Officer of 10% Security Holder, Senior Officer
Marc François Léger Senior Officer

Valeo Pharma Headlines

No Headlines